Post-Traumatic Stress Disorder (PTSD) 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for PTSD trials.

Effective solutions for advancing PTSD research

Post-Traumatic Stress Disorder (PTSD) is a psychiatric disorder that may occur in people who have experienced or witnessed a traumatic event. PTSD has largely been underserved in pharmaceutical research, which has made study teams less experienced in recognizing, diagnosing, and assessing changes in PTSD patients. Signant has the scientific expertise and innovative technology needed for sponsors to run a successful PTSD study.

 

PTSD-1

Why Signant Health

  • Administer Scales Consistently
  • Gain Expert Oversight
  • Standardize Rater Training
  • Optimize Signal Detection
  • Administer Scales Consistently

    Administer Scales Consistently

    We collaborated with internationally known PTSD experts to develop a comprehensive, electronic version of the CAPS-5 for our Electronic Clinician Ratings solution. With embedded training conventions and guidance, the electronic format collects reliable data to accurately diagnosis and detect changes in symptoms.
     
     
     

  • Gain Expert Oversight

    Gain Expert Oversight

    Signant’s scientific team ensures the highest level of training at the outset and throughout the course of the trial. Our in-house experts can also provide central reviews on the performed scales to ensure accuracy and consistency of data prior to submission.

     

     

  • Standardize Rater Training

    Standardize Rater Training

    Signant’s Rater Training & Qualification solution standardizes PTSD assessment techniques through a customized and comprehensive program. The curriculum focuses on scale knowledge as well as applied skills training and assessment for a wide variety of gold standard scales such as the SCID, MINI, and CAPS-5.
     
     

  • Optimize Signal Detection

    Optimize Signal Detection

    Select our PureSignal Analytics to reduce data issues caused by inconsistent assessments, which will improve your ability to detect signals. Proprietary algorithms examine COA data throughout your study to identify trends, anomalies, inconsistencies or discrepancies, enabling our in-house clinicians to deliver appropriate interventions.
     
     
     

Comprehensive psychiatry CNS experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our PTSD trial resources
SOLUTION BROCHURE

PTSD Trial Solutions Overview


GET INSIGHTS
VIDEO

PTSD Trial Solutions



WATCH [2 MIN]
SOLUTION

CNS Trial Solutions


 
EXPLORE FEATURES

Accelerate your PTSD trial success

Discover how Signant's specialized solutions can address unique challenges in your current or upcoming PTSD research.